Nalaganje...
Assessing the Risk for Gout With Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study
BACKGROUND: Hyperuricemia is common in patients with type 2 diabetes mellitus and is known to cause gout. Sodium–glucose cotransporter-2 (SGLT2) inhibitors prevent glucose reabsorption and lower serum uric acid levels. OBJECTIVE: To compare the rate of gout between adults prescribed an SGLT2 inhibit...
Shranjeno v:
| izdano v: | Ann Intern Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217750/ https://ncbi.nlm.nih.gov/pubmed/31931526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-2610 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|